http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110643034-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G2650-04 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-337 |
filingDate | 2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110643034-B |
titleOfInvention | Multi-arm PEG (polyethylene glycol) oritavancin derivative and preparation thereof |
abstract | The invention utilizes the characteristics of innocuity and easy combination of multi-arm PEG to respectively connect four-arm PEG, six-arm PEG and multi-arm PEG with oritavancin. The multi-arm PEG-loaded oritavancin prodrug has good water solubility, and the most important characteristic is that one multi-arm PEG chain can be connected with a plurality of oritavancin residues, so that the drug loading rate is greatly improved, and the half-life period of the drug is greatly prolonged, so that the existence time of the drug in plasma is remarkably prolonged, and the curative effect is improved. |
priorityDate | 2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.